Grantham, Mayo, Van Otterloo & Co (GMO)’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-28,700
| Closed | -$1.01M | – | 523 |
|
|
2018
Q2 | $1.01M | Sell |
28,700
-500
| -2% | -$17.6K | 0.01% | 352 |
|
|
2018
Q1 | $1.02M | Sell |
29,200
-3,800
| -12% | -$133K | 0.01% | 360 |
|
|
2017
Q4 | $1.15M | Buy |
33,000
+14,200
| +76% | +$493K | 0.01% | 340 |
|
|
2017
Q3 | $637K | Buy |
+18,800
| New | +$637K | ﹤0.01% | 382 |
|
|
2017
Q1 | – | Sell |
-240,631
| Closed | -$6.57M | – | 558 |
|
|
2016
Q4 | $6.57M | Sell |
240,631
-354,169
| -60% | -$9.68M | 0.04% | 204 |
|
|
2016
Q3 | $19.5M | Buy |
594,800
+7,600
| +1% | +$250K | 0.09% | 156 |
|
|
2016
Q2 | $17.7M | Buy |
587,200
+178,900
| +44% | +$5.4M | 0.07% | 175 |
|
|
2016
Q1 | $11.5M | Buy |
+408,300
| New | +$11.5M | 0.04% | 227 |
|
|
2014
Q3 | – | Sell |
-56,000
| Closed | -$2.08M | – | 435 |
|
|
2014
Q2 | $2.08M | Buy |
+56,000
| New | +$2.08M | 0.01% | 362 |
|